- Home
- NCV vs LXEO Comparison
NCV vs LXEO Comparison
Compare NCV & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NCV | LXEO |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 372.3M | 418.9M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | NCV | LXEO |
|---|---|---|
| Price | $16.73 | $5.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $18.44 |
| AVG Volume (30 Days) | 85.7K | ★ 716.9K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 12.48% | N/A |
| EPS Growth | N/A | ★ 39.81 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $654,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.93 | $2.43 |
| 52 Week High | $16.70 | $10.99 |
Technical Indicators
Market Signals| Indicator | NCV | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 67.19 | 43.50 |
| Support Level | $14.91 | $4.95 |
| Resistance Level | N/A | $6.08 |
| Average True Range (ATR) | 0.22 | 0.33 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 83.84 | 16.61 |
Price Performance
Historical ComparisonAbout NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.